Azelaic acid — mechanisms, evidence, and clinical applications.

Azelaic acid is a dicarboxylic acid found in small amounts in grains — wheat, barley, rye — and produced on the surface of most people's skin through the natural metabolic activity of Malassezia, a common skin-resident yeast. The azelaic acid used in cosmetics and pharmaceuticals is biosynthetically produced at consistent purity; the grain and microbial sources are simply where it was first identified.

It is an unusual active in that it has documented clinical effects on three distinct skin concerns — post-inflammatory hyperpigmentation, acne, and rosacea — and an unusually clean tolerability and safety profile, including in pregnancy, where most other effective brightening and acne actives carry cautions or contraindications.

Mechanism

Azelaic acid operates through several pathways simultaneously, which explains its broad clinical utility.

Tyrosinase inhibition. Azelaic acid selectively inhibits the activity of abnormally active melanocytes — the cells responsible for melanin overproduction in pigmentation disorders. The inhibition is preferential for hyperactive cells, which means it reduces excess pigmentation without significantly suppressing melanin production in normally functioning cells. This selectivity distinguishes azelaic acid from bleaching agents like hydroquinone, which affect all melanocytes indiscriminately.

Comedolytic and keratolytic activity. Azelaic acid normalises the abnormal keratinisation in follicular infundibula — the process by which dead skin cells accumulate and contribute to comedone formation. By moderating this process, it reduces the structural precondition for both blackheads and whiteheads.

Antibacterial activity. Azelaic acid inhibits the growth of Cutibacterium acnes (formerly Propionibacterium acnes), the bacterium most closely associated with inflammatory acne lesion development. The mechanism appears to be disruption of bacterial cellular metabolism rather than direct cell wall disruption.

Anti-inflammatory activity. Azelaic acid reduces the production of inflammatory mediators in keratinocytes and has been shown to inhibit the reactive oxygen species associated with neutrophil activity — the inflammatory pathway that produces the redness, swelling, and post-inflammatory pigmentation characteristic of both acne and rosacea.

Evidence

The clinical evidence base for azelaic acid is substantial, particularly at prescription concentrations.

At 15–20% (the concentration used in prescription formulations), azelaic acid has been shown in randomised controlled trials to reduce both inflammatory and non-inflammatory acne lesions and to produce statistically significant improvement in rosacea, including reduction in papules, erythema, and telangiectasia.

At 10% (the concentration available in OTC cosmetic formulations in most markets), the evidence is consistent with meaningful improvement in post-inflammatory hyperpigmentation and mild-to-moderate acne, though the effect size is smaller than at prescription concentrations. Studies comparing 10% azelaic acid to 4% hydroquinone and kojic acid in PIH treatment have generally found comparable or slightly inferior results to hydroquinone, with better tolerability.

The compound is one of the few skin actives categorised as safe for use during pregnancy by dermatologists and relevant regulatory bodies in most markets, based on the available evidence. This makes it clinically relevant for PIH treatment in a population that cannot use retinoids or hydroquinone.

Tolerability

Azelaic acid is well tolerated by most skin types. Mild transient tingling, stinging, or erythema on application is common when beginning use, particularly with higher concentrations, and typically resolves over the first one to two weeks as the skin acclimates.

Unlike AHAs, azelaic acid is not a photosensitiser. It does not require adjustment of UV precautions beyond what is already important for any hyperpigmentation protocol — which is to say, daily SPF is important because UV exposure continuously re-stimulates the melanin production that azelaic acid is suppressing. But the risk of acute photosensitisation is not azelaic acid's mechanism.

Concentrations and formulation

Prescription azelaic acid (15% gel, 20% cream) is available in most markets through a dermatologist. OTC formulations typically contain 10%. Below 10%, the active ingredient becomes less predictable as a treatment; lower concentrations are sometimes found in products where azelaic acid is functioning as a supporting rather than primary active.

Formulation stability is not a significant concern with azelaic acid; it is more chemically stable than vitamin C or kojic acid and does not require special storage beyond keeping it away from extreme heat.

Combining azelaic acid with other actives

Azelaic acid is compatible with niacinamide, alpha-arbutin, vitamin C, retinoids, AHAs, and SPF. It can be layered in a routine without meaningful antagonistic interactions.

Combining azelaic acid with niacinamide creates a complementary approach to hyperpigmentation: azelaic acid inhibits tyrosinase in melanocytes; niacinamide inhibits the transfer of melanosomes from melanocytes to the surrounding keratinocytes where the pigmentation actually becomes visible. They target adjacent steps in the same process.

There is no requirement to separate azelaic acid from other actives by application timing, though it is practical to apply treatments in order of consistency and to leave it on the skin rather than layering it with a product that might dilute or occlude it before it has absorbed.

The Lux & Glo position

The core ritual is built around three steps that address the foundational needs of most skin — cleanse, treat with niacinamide, hydrate. Azelaic acid belongs in the treatment category for skin managing active acne, rosacea, or persistent post-inflammatory hyperpigmentation, and is one of the cleaner additions to a routine for people in those situations.

The principle is consistent with everything else in the approach: understand what a single active does and why, and choose based on the specific condition being addressed rather than product marketing. Azelaic acid earns its place in a routine through mechanism and evidence. That is the brief.